Susan Bobulsky, Chief Commercial Officer, MRD at Adaptive Biotechnologies Corp (ADPT), sold 41,338 shares at $13.17 ($544K) on 2026-03-11, disclosed to the SEC on 2026-03-13.
Open-market sale of $544k ADPT by Chief Commercial Officer, MRD. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2026-08-12 | $75K | — | Filing → |
| ADPT | SELL | 2026-08-03 | $31K | — | Filing → |
| ADPT | SELL | 2026-07-20 | $115K | — | Filing → |